CM
CapDecisif Management
Venture CapitalActiveVC firm with a focus on early-stage innovative companies with high-growth potential
82
Investments
5
Exits
$500M
AUM
6.1%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for CapDecisif Management.
Investment Thesis & Strategy
CapDecisif Management invests in various stages of innovative, high-growth companies, with a focus on early-stage opportunities. They seek to partner with companies that demonstrate strong potential for rapid expansion.
Investment Activity
Deals per year over the last 5 years
4
20162
20173
20182
20191
2020Portfolio Companies
Selected investments from their portfolio of 82 companies
A
Agicap
Fintech · Series A, 2020
O
Owkin
Healthcare · Series A, 2019
I
Inato
Healthcare · Series A, 2019
E
Exotec
Robotics · Series B, 2018
D
DNAlytics
AI/ML · Series A, 2018
B
BioAge Labs
Biotech · Series A, 2018
L
LumApps
SaaS · Series B, 2017
D
Deepomatic
AI/ML · Series A, 2017
J
Jobteaser
EdTech · Series B, 2016
D
DNA Script
Biotech · Series A, 2016
S
Shift Technology
AI/ML · Series B, 2016
V
Vade Secure
Cybersecurity · Series A, 2016
Notable Exits
CompanyTypeYearValue / Acquirer
LedgerAcquisition2023—
Shift TechnologyIPO2021—
WiztiviAcquisition2021—
Vade SecureAcquisition2019—
EconocomAcquisition2018—
Frequently Asked Questions
CapDecisif Management focuses on Series A, Series B, Series C+ stage investments.